Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2406327Generated: October 31, 2026

p-Toluenesulfonic acid → (5-Chloro-2-fluoro-4-(4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)phenyl)-(morpholino)methanone

https://huagongshe.com/reaction/2406327

Reaction equation

Participants

RoleNameHCIDCharge
Reactantp-Toluenesulfonic acidHCID 6101—
ReactantMorpholineHCID 8083—
ReactantDiisopropylethylamineHCID 81531—
ReactantSodium BicarbonateHCID 516892—
ReactantMethanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 9886157—
Reactant2-Chloro-N-methyl-5-(trifluoromethyl)pyrimidin-4-amineHCID 21077587—
ReactantTert-butyl 4-amino-5-chloro-2-fluorobenzoateHCID 68684306—
SolventWaterHCID 962—
SolventDichloromethaneHCID 6344—
SolventTrifluoroacetic acidHCID 6422—
Product(5-Chloro-2-fluoro-4-(4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)phenyl)-(morpholino)methanoneHCID 7158512828.8%

Reaction Conditions

Temperature100 °C

Reaction Steps

A solution of tert-butyl 4-amino-5-chloro-2-fluorobenzoate (50 mg, 0.20 mmol) in dichloromethane (2 mL) and trifluoroacetic acid (2 mL) was stirred at room temperature for 3 hours then the reaction was evaporated to dryness. The residue was taken up in dioxane (3 mL) then 2-chloro-N-methyl-5-(tri-fluoromethyl)pyrimidin-4-amine (42 mg, 0.20 mmol) and para-toluene sulfonic acid (38 mg, 0.20 mmol) were added. The resulting mixture was heated to 100° C. for 2 h. After return to room temperature, DCM (10 mL) and water (10 m) were added and the organic phase was passed through a hydrophobic frit. The solvent was removed in vacuo and the residue was dissolved in DCM (3 mL) and then DIPEA (140 μL, 0.8 mmol) and HATU (85 mg, 0.22 mmol) were added, followed by morpholine (18 μL, 0.2 mmol). The mixture was allowed to stir at RT for 4 h and then saturated aqueous sodium bicarbonate solution (25 mL) was added. The mixture was passed through a hydrophobic frit and the solvent was removed in vacuo. The residue was purified by reversed phase HPLC to give (5-chloro-2-fluoro-4-(4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)phenyl)-(morpholino)methanone (25 mg, 28%) as an off-white solid. LCMS (10 cm_ESCI_Bicarb_MeCN): [M+H]+=434 at 3.02 min. 1H NMR (400 MHz, CDCl3): δ 8.64 (d, J=12.8 Hz, 1H), 8.22 (s, 1H), 7.72 (brs, 1H), 7.48 (d, J=6.8 Hz, 1H), 5.30 (brs, 1H), 3.80-3.77 (m, 4H), 3.66-3.68 (m, 2H), 3.41-3.39 (m, 2H), 3.12 (d, J=4.8 Hz, 3H).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08809331B2
Source datasetuspto-grants-2014_08
ORD IDord-82227033653b46d8a67b01ebe2adff87
Source noteuspto-grants-2014_08